CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daling, J. R.
Right arrow Articles by Porter, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daling, J. R.
Right arrow Articles by Porter, P. L.
Cancer Epidemiology Biomarkers & Prevention Vol. 11, 235-241, March 2002
© 2002 American Association for Cancer Research

The Relation of Reproductive Factors to Mortality from Breast Cancer1

Janet R. Daling2, Kathleen E. Malone, David R. Doody, Benjamin O. Anderson and Peggy L. Porter

Fred Hutchinson Cancer Research Center, Divisions of Public Health Sciences [J. R. D., K. E. M., D. R. D., P. L. P.] and Human Biology [P. L. P.], and Clinical Division [B. O. A.], Seattle, Washington 98109-1024, and University of Washington, School of Public Health and Community Medicine, Department of Epidemiology [J. R. D., K. E. M.], and School of Medicine, Departments of Surgery [B. O. A.] and Pathology [P. L. P.], Seattle, Washington 98195

Young women with breast cancer have been reported to have an increased risk of dying from their disease if they have given birth in <2 years before diagnosis. The prognostic factors associated with the tumors of these women have not been thoroughly studied. We examined the tumors of the women who had a recent birth and compared the tumor characteristics with those of women who were nulliparous or had given birth >=5 years before diagnosis. A follow-up study was conducted of 1174 women <45 years old whose invasive ductal breast cancer was diagnosed from January 1983 to December 1992 in three counties of western Washington. These women had participated previously in a population-based, case-control study. Mean follow-up time was 105.4 months. Histological slides were collected for 79.1% of the tumors and reviewed by the study pathologist. Using immunoperoxidase assays, tumor tissue was tested for prognostic markers for 70.4% of the tumors from the women. Cox proportional hazards models were used to estimate the relative risk of dying from breast cancer associated with reproductive events. Logistic regression was used to obtain estimates of the association between various reproductive factors and tumor characteristics. At the end of follow-up, 48.2% of the women (n = 83) whose last birth occurred in <2 years of diagnosis had died, compared with 23.3% of nulliparous women (n = 189) and 24.4% of the women (n = 661) whose last birth was >=5 years before diagnosis. The tumors of the women with a recent birth (<2 years before diagnosis) were more likely to be progesterone receptor negative, odds ratio (OR) = 2.2, 95% confidence interval (CI) = 1.2–3.9, to be p53 positive, OR = 2.6, 95% CI = 1.5–4.7, to be of high histological grade, OR = 5.9, 95% CI = 1.7–20.1, to have high mitotic count, OR = 2.2, 95% CI = 1.4–4.4, to be node positive, OR = 2.1, 95% CI = 1.3–3.5, to have a high S phase fraction, OR = 2.3, 95% CI = 1.1–4.8, and to have a high American Joint Committee on Cancer stage (III+), OR = 2.8, 95% CI 1.3–5.8, compared with the tumors of nulliparous women. After adjusting for tumor characteristics and treatment, the risk of mortality associated with a birth in <2 years of diagnosis of breast cancer remained an independent predictor of mortality, hazard radio (HR) = 2.7, 95% CI = 1.6–4.3. Our study provides evidence that reproductive factors influence the biological behavior of breast cancer in young women and prognosis. Clinicians need to be aware that women who have delivered a child in <2 years before diagnosis are at increased risk of having tumors with especially adverse prognostic profiles and have a poorer survival rate than women who are nulliparous or whose last birth was some years in the past.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
L. Dodds, D. B. Fell, K. S. Joseph, R. Dewar, H. Scott, R. Platt, and K. J. Aronson
Relationship of Time Since Childbirth and Other Pregnancy Factors to Premenopausal Breast Cancer Prognosis
Obstet. Gynecol., May 1, 2008; 111(5): 1167 - 1173.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. M. Brewster, K.-A. Do, P. A. Thompson, K. M. Hahn, A. A. Sahin, Y. Cao, M. M. Stewart, J. L. Murray, G. N. Hortobagyi, and M. L. Bondy
Relationship Between Epidemiologic Risk Factors and Breast Cancer Recurrence
J. Clin. Oncol., October 1, 2007; 25(28): 4438 - 4444.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Kuorelahti, S. Rulli, I. Huhtaniemi, and M. Poutanen
Human Chorionic Gonadotropin (hCG) Up-Regulates wnt5b and wnt7b in the Mammary Gland, and hCG{beta} Transgenic Female Mice Present with Mammary Gland Tumors Exhibiting Characteristics of the Wnt/{beta}-Catenin Pathway Activation
Endocrinology, August 1, 2007; 148(8): 3694 - 3703.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Agrawal, J. H. Chen, C. H. Baick, A. E. Chen, R. S. Mehta, O. Nalcioglu, and M.-Y. Su
Pathological Complete Response in Triple Negative Poorly Differentiated Invasive Ductal Breast Carcinoma Detected During Pregnancy
J. Clin. Oncol., June 20, 2007; 25(18): 2618 - 2620.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Sonnenschein and A. M. Soto
Carcinogenesis and Metastasis Now in the Third Dimension--What's in It for Pathologists?
Am. J. Pathol., February 1, 2006; 168(2): 363 - 366.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. M. McDaniel, K. K. Rumer, S. L. Biroc, R. P. Metz, M. Singh, W. Porter, and P. Schedin
Remodeling of the Mammary Microenvironment after Lactation Promotes Breast Tumor Cell Metastasis
Am. J. Pathol., February 1, 2006; 168(2): 608 - 620.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
M. K. Whiteman, S. D. Hillis, K. M. Curtis, J. A. McDonald, P. A. Wingo, and P. A. Marchbanks
Reproductive History and Mortality After Breast Cancer Diagnosis
Obstet. Gynecol., July 1, 2004; 104(1): 146 - 154.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K.-A. Phillips, R. L. Milne, M. L. Friedlander, M. A. Jenkins, M. R.E. McCredie, G. G. Giles, and J. L. Hopper
Prognosis of Premenopausal Breast Cancer and Childbirth Prior to Diagnosis
J. Clin. Oncol., February 15, 2004; 22(4): 699 - 705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2002 by the American Association for Cancer Research.